E
ZyVersa Therapeutics, Inc. ZVSA
$0.1221 -$0.0079-6.08% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 6.52M 6.93M 7.36M 7.71M 8.11M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 7.74M 8.45M 9.14M 9.63M 10.26M
Operating Income -7.74M -8.45M -9.14M -9.63M -10.26M
Income Before Tax -8.29M -8.84M -9.41M -21.92M -22.42M
Income Tax Expenses -3.00K 6.70K 6.70K -586.40K -586.90K
Earnings from Continuing Operations -8.29 -8.84 -9.41 -21.33 -21.83
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -8.29M -8.84M -9.41M -21.33M -21.83M
EBIT -7.74M -8.45M -9.14M -9.63M -10.26M
EBITDA -7.74M -8.45M -9.13M -9.62M -10.25M
EPS Basic -4.33 -7.18 -10.99 -72.35 -100.10
Normalized Basic EPS -2.71 -4.48 -6.86 -11.58 -28.72
EPS Diluted -4.33 -7.18 -10.99 -72.35 -100.10
Normalized Diluted EPS -2.71 -4.48 -6.86 -11.58 -28.72
Average Basic Shares Outstanding 10.90M 6.92M 4.44M 2.66M 1.77M
Average Diluted Shares Outstanding 10.90M 6.92M 4.44M 2.66M 1.77M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --